Science & Enterprise logo
Science for business people. Enterprise for scientists.
  • GSK, UNC Chapel Hill Partner on HIV/AIDS Cure

    11 May 2015. Pharmaceutical maker GlaxoSmithKline and University of North Carolina in Chapel Hill are establishing a joint research center and spin-off company to develop new treatments for HIV and AIDS. GSK says it plans to invest $20 million over 5 years for a new HIV Cure Center on the Chapel Hill campus to conduct…

  • NASA Challenge Seeks Elements for Human Presence on Mars

    8 May 2015.   NASA is asking the public for ideas on ways to establish a long-term presence of Mars in a new challenge offered by InnoCentive. The competition has a total purse of $15,000 and a deadline for submissions of 6 July 2015. InnoCentive in Waltham, Massachusetts conducts open-innovation, crowdsourcing competitions for corporate and organization…

  • Clinical Trial Testing West Nile Vaccine

    7 May 2015. A vaccine for West Nile virus, a seasonal infection spread by mosquitoes, is being tested for safety in an early stage clinical trial. The vaccine, code-named HydroVax-001, is being developed in the lab of microbiologist Mark Slifka at Oregon Health and Science University in Beaverton and commercialized by Najit Technologies Inc., a…

  • Standard Devised to Cut Poultry Antibiotic Use

    7 May 2015. An organization of school districts in the U.S., joined by the Pew Charitable Trusts and U.S. Department of Agriculture, wrote a set of guidelines to reduce the use of antibiotics in raising chickens destined for school feeding programs. Tyson Foods, the nation’s largest producer of chickens, also revealed today it is adopting…

  • Eli Lilly Opening Drug Delivery, Device Research Center

    6 May 2015. Pharmaceutical maker Eli Lilly and Company is opening a new research facility in Cambridge, Massachusetts concentrating on drug delivery and medical devices. The research center, in Cambridge’s Kendall Square, is expected to open by the end of 2015 and hire some 30 scientists and engineers. The need for innovation in drug delivery…

  • New Company Founded to Develop Centimeter-Accurate GPS

    Video: Centimeter-level GPS used in a virtual reality headset (University of Texas, Austin) 6 May 2015. An engineering lab at University of Texas in Austin designed a low-cost portable global positioning system with precision to a few centimeters, and started a company to take the technology to market. A team from UT-Austin’s Radionavigation Laboratory, led…

  • 23andMe, Lupus Institute Partner on Genetics Study

    5 May 2015. The personal genetics company 23 andMe and Lupus Research Institute are collaborating on a study of genetic associations with systemic lupus erythematosus, the disease more commonly known as lupus. Financial and intellectual property details of the collaboration between 23andMe, Lupus Research Institute, and Pfizer Inc. serving as an adviser to the project,…

  • Trial Underway Testing RNA Therapy for Rare Liver Disorder

    5 May 2015. An early-stage clinical trial is testing a therapy derived from genetic material to treat alpha-1 antitrypsin deficiency, a rare inherited disease affecting the liver and lungs. The therapy, code-named ARC-AAT, is developed by Arrowhead Research Corporation, a biopharmaceutical company in Pasadena, California. Alpha-1 antitrypsin deficiency, or AATD, is caused by a mutation…

  • Cancer Therapy Spin-Off Gets $2M Small Business Grant

    4 May 2015. A three year-old company started by a University at Buffalo microbiologist received a $2 million grant to develop an antibody into a clinical treatment for breast and other types of cancer. For-Robin in Williamsville, New York, received the two-year award from National Cancer Institute, part of National Institutes of Health, under the…

  • Stem Cells Treat Vision Disorders in Animal Tests

    4 May 2015. Tests with lab rats of a therapy for degenerating retinas in the eyes, show the treatments derived from human embryonic stem cells can restore visual functions. Results of the treatments, developed by Cell Cure Neurosciences Ltd., are scheduled to be reported today by a research team from Oregon Health and Science University…